ArticlePoultry science2026
Cross‑kingdom antiviral action of Scutellaria baicalensis Georgi and Chrysanthemum indicum L. miRNAs: A novel strategy against duck viral hepatitis.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Duck viral hepatitis (DVH) requires novel therapeutic strategies. This study investigated antiviral miRNAs in separate decoctions of Scutellaria baicalensis Georgi and Chrysanthemum indicum L. High-throughput sequencing identified 14 highly expressed miRNAs, which were chemically synthesized for functional validation. CCK8 assay quantified cytoprotection in duck embryonic hepatocytes (DEHs) and RT-qPCR measured DHAV-1 gene expression, enabling the selection of the most effective miRNAs. Two candidates, novel-miR2 (from S. baicalensis) and novel-miR10 (from C. indicum), were selected for detailed study. RT-qPCR along with fluorescent probes assessed miRNA concentrations, stability, and their effects on DEHs biological characteristics. In vivo evaluations included mortality rates, liver histopathology/function, and markers of inflammation/apoptosis. Both miRNAs exhibited differential concentrations in fresh versus dried herbs and demonstrated good thermal stability. In vitro, miRNAs reduced DHAV-1 replication, apoptosis, necrosis, and ROS, while enhancing cell viability. Oral administration improved survival rates in infected ducklings, lowered serum liver enzymes, and alleviated hepatic damage. Specifically, novel-miR2 predominantly reduced apoptosis, whereas novel-miR10 alleviated inflammation. Collectively, novel-miR2 and novel-miR10 suppressed DHAV-1-induced hepatitis, exerting hepatoprotective effects. These findings provided new evidence for clarifying the active constituents of herbal decoctions and their miRNA‑mediated cross‑kingdom antiviral mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.